Fate Therapeutics (NASDAQ:FATE) stock rallied 37% Monday after the company reported that the first patient in the Phase 1 ...
Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...
Evie is receiving a chemotherapy treatment plan that is a result of decades of donor supported clinical trials. Donations ...
Fate Therapeutics (FATE) presented initial clinical and translational data from the company’s Phase 1 study of FT522 in relapsed / refractory ...
"When you know that your granddaughter, who at that point wasn't even a year old, has already done that treatment, it made me ...
Former Hollyoaks star Ali Bastian has shared an update on her treatment for breast cancer. Bastian, who played Becca Dean on ...
In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...
The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...
The U.S. Department of Labor’s Wage and Hour Division issued an opinion letter on Nov. 8, 2024, affirming that employees may use Family and ...
A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...
Faced with a diagnosis of an incurable, life-threatening condition, for some the answer to their prayers can come in the form ...